Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KIND: Ketamine for Neuroprotection in SAH
NCT02636218Phase 3Completed
- Sponsor
- Unity Health Toronto
- Start
- Jan 2016
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Unity Health Toronto. Started Jan 2016; status: completed.
02
Drugs
ketamine
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT02636218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02636218.